Publisher
Springer Science and Business Media LLC
Reference160 articles.
1. Sharpe, E., Hoey, R., Yap, C. & Workman, P. From patent to patient: analysing access to innovative cancer drugs. Drug Discov. Today 25, 1561–1568 (2020).
2. Biotechnology Innovation Organization, Biomedtracker & Amplion. Clinical Development Success Rates 2006-2015 bio.org https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf (2016).
3. Workman, P., Draetta, G. F., Schellens, J. H. M. & Bernards, R. How much longer will we put up with 100,000 cancer drugs? Cell 168, 579–583 (2017).
4. Workman, P. How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development. Curr. Pharm. Des. 9, 891–902 (2005).
5. Yap, T. A., Sandhu, S. K., Workman, P. & de Bono, J. S. Envisioning the future of early anticancer drug development. Nat. Rev. Cancer 10, 514 (2010).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献